Clinical Trial Update: Role of TXA in Patients Undergoing Breast Free Flap Reconstruction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating tranexamic acid (TXA) to reduce surgical blood loss in patients undergoing breast free flap reconstruction for breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Virginia | Conditions: Breast Cancer, Blood Loss, Surgical | Phase 4 | Status: RECRUITING